Navigation Links
Zimmer Reports Fourth Quarter and 2007 Financial Results
Date:1/29/2008

n Corrupt Practices Act matters announced in October 2007, price and product competition, rapid technological development, demographic changes, dependence on new product development, the mix of our products and services, supply and prices of raw materials and products, customer demand for our products and services, control of costs and expenses, our ability to form and implement alliances, international growth, governmental laws and regulations affecting our U.S. and international businesses, including tax obligations and risks, product liability and intellectual property litigation losses, reimbursement levels from third-party payors, general industry and market conditions and growth rates and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. For a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

ZIMMER HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF EARNINGS

FOR THE THREE MONTHS ENDED DECEMBER 31, 2007 and 2006

(in millions, except per share amounts, unaudited)

2007 2006 % Inc/(Dec)

Net Sales $1,073.5 $933.6
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
2. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
3. Zimmer Holdings to Present at JPMorgan Healthcare Conference
4. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings to Present at Upcoming Investor Conferences
7. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
9. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... , WASHINGTON -- A new report from the Institute...ts, duty hours and workloads to decrease the chanc...e the learning environment for these doctors in tr...ucing residents, work hours from the maximum avera... for Graduate Medical Education (ACGME) in 2003, b...
(Date:12/2/2008)...California Health System Builds Resilient, Cost an... , HOPKINTON, Mass., Dec. 2 EM...information infrastructure solutions, today announ...CHS), a regional system of six hospitals spanning ... servers and implemented business continuity funct...
(Date:12/2/2008)...DENVER, Dec. 2 Barotz Dental is no...ring LANAP(TM) (Laser Assisted New Attachment,Pro...tocol that is patented,and FDA approved for new a... LANAP removes diseased tissue, without remov...issue around teeth, minimizes pain and discomfort ...
(Date:12/2/2008)...FISHERS, Ind., Dec. 2 A number of ...ise in childhood obesity, the health risks in,ove... value of cereals and,other foods kids consume. ...- offers all natural, freeze-dried real fruit prod...s, but also provide most, if not all, of the daily...
Breaking Medicine News(10 mins):Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
... nutrition while pregnant may be more likely to be... A team from the University of Amsterdam looked at...uring the Dutch famine of 1944-1945 which followed...ey found that the rate of obesity among the women,...
...er antioxidant effects than orange juice. accordin... food. The study states that, people who are look... increased antioxidant consumption might prefer a ...rning to orange juice," says Joe A. Vinson, profes...
...eart disease than those with a full head of hair, ...he Archives of Internal Medicine, said they found ...ease and hair loss. The type of baldness also see...d to develop heart disease.// Those with frontal b...
...ort immunity in elderly, frail and patients at ris... rate of infection is a common risk, especially fo...at the University of Pittsburgh report on the use ...s the immune system in patients undergoing surgery...
Other Medicine News:
(Date:12/2/2008)...re-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ),...prietary antibodies for the treatment of cancer, i...ed that it has entered into an agreement expanding...th Kingsbridge Capital Limited, a private investme...bridge has committed to provide up to $75 million ...
(Date:12/1/2008)...-- TargeGen has announced that an oral,presentati...-based clinical,trial of TG101348 in myeloprolife... 2008 American Society of Hematology (ASH) Meeting...llows:, Title: A Phase I Study ... JAK2-Selective Inhibitor, in Patients w...
(Date:12/1/2008)...gene is a two-way switch that, if turned off, caus...so that they lose their identity and become more l...nn., Dec. 1 Scientists...covered that a certain differentiated cell type is...the constant expression of a gene called Prox1 t...
(Date:12/1/2008)...r Tuesday, December 9 at 11:00 am ET to Discuss Ph...N FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCal...S ), a biopharmaceutical company focused on the de...erapeutics, today announced new data from its stud...ill be presented during the 50th American Society ...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 1NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African American Voters 28477 2Easy Ethnic Election 28475 1Easy Ethnic Election 28475 2FDA Faulted for Stance on Chemical in Plastics 28471 1FDA Faulted for Stance on Chemical in Plastics 28471 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 13SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 23SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 33SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 43SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 53SBio Inc Announces Preliminary Third Quarter 2008 Results 8793 6
...is, often conducted in a physicians office practic...array of ailments; UTIs, diabetes, several cancers...iseases. The estimated global market for urinalys...r and is growing strongly. For such a fundamental,...rocedure, the manufacturers of urinalysis analyzer...
...cois Rossi Medical Hematology and Oncology CHU Lap...RP) is an acute-phase protein that has long been r...P measurement can complement a range of diagnostic.... However, as economic rationalization becomes a ... apparent that such areas of frequent laboratory t...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model.
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Medium 23 mm. Overall length: 3.9 inches.
One end with needle point and other end with medium taper. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches.
Medicine Products: